Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Gorlick

Showing results (11-20 of 281) with videos related to

Pageof 29
Sort By:
The Lancet. Oncology|December 29, 2009
IGF-1R targeted treatment of sarcomaJeffrey A Toretsky, Richard Gorlick
Current Oncology Reports|June 11, 2009
Development of IGF-IR Inhibitors in Pediatric SarcomasE Anders Kolb, Richard Gorlick
Expert Opinion on Pharmacotherapy|December 17, 2009
HER-2 targeted treatment of osteosarcoma: the challenges of developing targeted therapy and prognostic factors for rare malignanciesDavid S Geller, Richard Gorlick
Clinical Advances in Hematology & Oncology : H&O|February 15, 2011
Osteosarcoma: a review of diagnosis, management, and treatment strategiesDavid S Geller, Richard Gorlick
Advances in Experimental Medicine and Biology|June 14, 2014
HER-2 involvement in osteosarcomaJonathan Gill, David Geller, Richard Gorlick
Annals of Surgical Oncology|July 8, 2015
Collaborations between SSO and the Connective Tissue Oncology Society (CTOS) seriesPeter Hohenberger, Richard Gorlick, Alessandro Gronchi
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcomaRui Yang, Sajida Piperdi, Richard Gorlick
Journal of Pediatric Hematology/Oncology|September 22, 2012
Current practice managements regarding thromboembolic prophylaxis within the pediatric sarcoma patient populationLauren Crocco, Richard Gorlick, David S Geller
Oncogene|August 21, 2019
Induction of NKG2D ligand expression on tumor cells by CD8<sup>+</sup> T-cell engagement-mediated activation of nuclear factor-kappa B and p300/CBP-associated factorJiemiao Hu, Xueqing Xia, Richard Gorlick, et al.
Advances in Experimental Medicine and Biology|June 3, 2020
HER2-Targeted Therapy in OsteosarcomaJonathan Gill, Pooja Hingorani, Michael Roth, et al.
Pageof 29

Showing results (11-20 of 281) with videos related to

Sort By:
Pageof 29
The Lancet. Oncology|December 29, 2009
IGF-1R targeted treatment of sarcomaJeffrey A Toretsky, Richard Gorlick
Current Oncology Reports|June 11, 2009
Development of IGF-IR Inhibitors in Pediatric SarcomasE Anders Kolb, Richard Gorlick
Expert Opinion on Pharmacotherapy|December 17, 2009
HER-2 targeted treatment of osteosarcoma: the challenges of developing targeted therapy and prognostic factors for rare malignanciesDavid S Geller, Richard Gorlick
Clinical Advances in Hematology & Oncology : H&O|February 15, 2011
Osteosarcoma: a review of diagnosis, management, and treatment strategiesDavid S Geller, Richard Gorlick
Advances in Experimental Medicine and Biology|June 14, 2014
HER-2 involvement in osteosarcomaJonathan Gill, David Geller, Richard Gorlick
Annals of Surgical Oncology|July 8, 2015
Collaborations between SSO and the Connective Tissue Oncology Society (CTOS) seriesPeter Hohenberger, Richard Gorlick, Alessandro Gronchi
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcomaRui Yang, Sajida Piperdi, Richard Gorlick
Journal of Pediatric Hematology/Oncology|September 22, 2012
Current practice managements regarding thromboembolic prophylaxis within the pediatric sarcoma patient populationLauren Crocco, Richard Gorlick, David S Geller
Oncogene|August 21, 2019
Induction of NKG2D ligand expression on tumor cells by CD8<sup>+</sup> T-cell engagement-mediated activation of nuclear factor-kappa B and p300/CBP-associated factorJiemiao Hu, Xueqing Xia, Richard Gorlick, et al.
Advances in Experimental Medicine and Biology|June 3, 2020
HER2-Targeted Therapy in OsteosarcomaJonathan Gill, Pooja Hingorani, Michael Roth, et al.
Pageof 29